Harlan S Robins
Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 23SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 278,6981,025,760 held (−21%) | $21.72 | $6.1M | +22.0% |
| Jul 23SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 213,702812,058 held (−21%) | $22.12 | $4.7M | +19.8% |
| Jul 7SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 239,3511,166,547 held (−17%) | $21.74 | $5.2M | +21.8% |
| Jul 7SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 146,8891,019,658 held (−13%) | $22.45 | $3.3M | +18.0% |
| Jun 17SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 100,0001,412,058 held (−7%) | $17.37 | $1.7M | +52.5% |
| Jun 17SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 6,1601,405,898 held (−0%) | $18.01 | $111K | +47.1% |
| Apr 10SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 10,0001,512,058 held (−1%) | $14.85 | $148K | +78.4% |
| Mar 13SEC | ADPTAdaptive Biotechnologies Corp | Sell | 140,6661,851,658 held (−7%) | $13.17 | $1.9M | +101.1% |
| Mar 13SEC | ADPTAdaptive Biotechnologies Corp | Sell | 329,6001,522,058 held (−18%) | $13.17 | $4.3M | +101.1% |
| Mar 4SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 10,0001,169,524 held (−1%) | $15.72 | $157K | +68.5% |
| Mar 4SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 14,2331,155,291 held (−1%) | $16.52 | $235K | +60.4% |
| Feb 4SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 34,6681,187,644 held (−3%) | $18.60 | $645K | +42.4% |
| Feb 4SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 8,1201,179,524 held (−1%) | $19.00 | $154K | +39.4% |
| Jan 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 10,0001,222,312 held (−1%) | $16.44 | $164K | +61.1% |
| Dec 5SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 27,2121,242,312 held (−2%) | $18.61 | $506K | +42.3% |
| Dec 5SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 10,0001,232,312 held (−1%) | $16.61 | $166K | +59.5% |
| Nov 12SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 10,0001,269,524 held (−1%) | $14.82 | $148K | +78.7% |
- Sell
Chief Scientific Officer Harlan S Robins sold $6.1M of ADPT at $21.72 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Harlan S Robins sold $4.7M of ADPT at $22.12 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Harlan S Robins sold $5.2M of ADPT at $21.74 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Harlan S Robins sold $3.3M of ADPT at $22.45 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Harlan S Robins sold $1.7M of ADPT at $17.37 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Harlan S Robins sold $111K of ADPT at $18.01 — pre-scheduled 10b5-1 plan sale.